Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
Deloitte
Cantor Fitzgerald
Fuji
Covington
Harvard Business School
Chinese Patent Office
Baxter
Mallinckrodt
Farmers Insurance

Generated: February 25, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,136,794

« Back to Dashboard

Which drugs does patent 6,136,794 protect, and when does it expire?

Patent 6,136,794 protects AGGRASTAT and is included in two NDAs.

This patent has seven patent family members in six countries.
Summary for Patent: 6,136,794
Title: Platelet aggregation inhibition using low molecular weight heparin in combination with a GP IIb/IIIa antagonist
Abstract:A method for inhibiting platelet aggregation in a mammal comprising administering to the mammal a safe and therapeutically effective amount of a GPIIb/IIIa receptor antagonist or a pharmaceutically acceptable salt thereof and a safe and therapeutically effective amount of low molecular weight heparin. A method for inhibiting platelet aggregation in a mammal comprising administering to the mammal a safe and therapeutically effective amount of (2-S-(n-butylsulfonylamino)-3[4-(piperidin-4-yl)butyloxyphenyl]-propionic acid or a pharmaceutically acceptable salt thereof and a safe and therapeutically effective amount of low molecular weight heparin.
Inventor(s): Cook; Jacquelynn J. (Collegeville, PA), Gould; Robert J. (Green Lane, PA), Sax; Frederic L. (Villanova, PA)
Assignee: Merck & Co., Inc. (Rahway, NJ)
Application Number:09/240,429
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 6,136,794

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Medicure AGGRASTAT tirofiban hydrochloride INJECTABLE;INJECTION 020913-002 May 17, 2002 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Medicure AGGRASTAT tirofiban hydrochloride INJECTABLE;INJECTION 020912-001 May 14, 1998 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Medicure AGGRASTAT tirofiban hydrochloride INJECTABLE;INJECTION 020913-003 Apr 20, 2000 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Medicure AGGRASTAT tirofiban hydrochloride INJECTABLE;INJECTION 020913-001 May 14, 1998 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Medicure AGGRASTAT tirofiban hydrochloride SOLUTION;INJECTION 020912-002 Aug 31, 2016 RX Yes Yes ➤ Sign Up ➤ Sign Up METHOD OF INHIBITING PLATELET AGGREGATION WITH AGGRASTAT (TIROFIBAN HYDROCHLORIDE) ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 6,136,794

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Japan 2002501936 ➤ Sign Up
United Kingdom 9809793 ➤ Sign Up
European Patent Office 1068172 ➤ Sign Up
Canada 2318215 ➤ Sign Up
Australia 740941 ➤ Sign Up
Australia 2350699 ➤ Sign Up
World Intellectual Property Organization (WIPO) 9938827 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Daiichi Sankyo
Merck
Julphar
Mallinckrodt
Moodys
McKinsey
Accenture
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot